Cambodia is among 11 nations set to

benefit from a US$225 million anti-malarial fund launched in Oslo on

Friday by Roll-Back Malaria, a public private partnership that includes

UNICEF, the World Bank, private donors and various national

governments. The fund will cut the cost of drugs for resistant malarial

strains from $6-$10 to between $0.20 and $0.50 through international

subsidies and negotiations with pharmaceutical companies. Cambodia and

the 10 African nations selected are among the worst nations affected by

malaria, a disease that is estimated to kill 2,000 children a day

worldwide.